Profound Medical Corp.
General ticker "PROF" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $146.6M (TTM average)
Profound Medical Corp. follows the US Stock Market performance with the rate: 4.1%.
Estimated limits based on current volatility of 3.5%: low 6.41$, high 6.88$
Factors to consider:
- Total employees count: 8000 as of 2024
- US accounted for 60.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Limited operating history, High capital intensity, Market acceptance, Reimbursement risks, Partner dependency
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.99$, 10.05$]
- 2025-12-31 to 2026-12-31 estimated range: [3.70$, 9.33$]
Financial Metrics affecting the PROF estimates:
- Negative: with PPE of -6.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -13.25 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 86.03 > 63.39
Short-term PROF quotes
Long-term PROF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $6.68MM | $7.20MM | $10.68MM |
| Operating Expenses | $38.81MM | $35.85MM | $43.74MM |
| Operating Income | $-32.13MM | $-28.65MM | $-33.06MM |
| Non-Operating Income | $3.74MM | $0.20MM | $5.24MM |
| Interest Expense | $0.17MM | $0.00MM | $0.00MM |
| R&D Expense | $14.69MM | $14.42MM | $16.96MM |
| Income(Loss) | $-28.38MM | $-28.45MM | $-27.82MM |
| Taxes | $0.29MM | $-0.13MM | $-0.00MM |
| Profit(Loss)* | $-28.67MM | $-28.57MM | $-26.48MM |
| Stockholders Equity | $52.00MM | $31.22MM | $60.42MM |
| Inventory | $7.94MM | $6.99MM | $5.80MM |
| Assets | $64.42MM | $43.96MM | $70.23MM |
| Operating Cash Flow | $-25.80MM | $-22.61MM | $-23.45MM |
| Financing Cash Flow | $7.03MM | $1.76MM | $54.70MM |
| Earnings Per Share** | $-1.38 | $-1.35 | $-1.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.